Related Experiment Video
Updated: May 25, 2026

08:33
A Randomized, Sham-Controlled Trial of Cranial Electrical Stimulation for Fibromyalgia Pain and Physical Function, Using Brain Imaging Biomarkers
Published on: January 5, 2024
Brain imaging in fibromyalgia syndrome
1Division of Rheumatology and Clinical Immunology, University of Florida, Gainesville, FL 32610-0221, USA. staudr@ufl.edu
Clinical and Experimental Rheumatology
|January 17, 2012
Summary
Fibromyalgia (FM) involves central nervous system changes, not just peripheral pain. Brain imaging reveals altered pain processing and connectivity in FM patients, offering insights into pain regulation.
Area of Science:
- Neuroscience
- Pain Medicine
- Medical Imaging
Background:
- Fibromyalgia (FM) is a chronic pain syndrome with widespread pain and heightened sensitivity.
- Focus is shifting to central nervous system (CNS) abnormalities like central sensitization.
- Functional brain imaging is key to understanding FM's abnormal pain processing.
Purpose of the Study:
- To review functional brain imaging findings in Fibromyalgia.
- To explore altered brain activity, connectivity, and neurotransmitter levels in FM.
- To identify neural correlates of pain modulation in FM.
Main Methods:
- Review of functional brain imaging studies (fMRI, MRS) in Fibromyalgia patients.
- Analysis of brain activity within the 'pain matrix' and network connectivity.
- Correlation of neuroimaging findings with pain sensitivity and neurotransmitter concentrations.
Main Results:
- FM patients show increased activity in pain-related brain areas and altered network connectivity.
- Elevated glutamate levels in pain-processing regions correlate with pain ratings.
- Brain imaging demonstrates abnormal processing of pain, including temporal summation and aftersensations.
Conclusions:
- Functional brain imaging provides strong evidence for CNS-based pain processing abnormalities in FM.
- Altered brain activity and connectivity are central to FM pathophysiology.
- Future research should focus on endogenous pain modulation mechanisms for therapeutic targets.

